Viking Therapeutics (VKTX) Q2 2026 Earnings

29AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.38
-1.07
-0.76
-0.45

Details

Expected EPS
-0.996862
Actual EPS
N/A
Surprise EPS
1
Surprise Percent
+100%

Description

Viking Therapeutics (VKTX) will report earnings of for Q2 2026 on April 29, 2026.

0 Comments

Share your thoughts